Reshaping Clinical Trial Designs with Real-World Data
Neal Meropol, head of research oncology at Flatiron Health, discusses how real-world evidence can inform better clinical trial designs and accelerate drug development, how Flatiron works with its clients, and a recent study he was involved in that suggest drug developers who want to increase the diversity of clinical trials participants should consider broadening their inclusion criteria.